Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARCERII: Hypofractionated Radiation in Cervical and Endometrial Tumours
NCT05857631Recruiting
- Sponsor
- Tata Memorial Centre
- Start
- May 2023
- Primary completion
- May 2029
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Tata Memorial Centre. Primary endpoint: Cumulative incidence of grade ≥2 gastrointestinal or genitourinary toxicity at 3 years. Started May 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05857631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05857631.